India wants 5-year IPR waiver on Covid tests, treatments

India wants 5-year IPR waiver on Covid tests, treatments At a meeting of the Trade-related Aspects of Intellectual Property Rights (TRIPS) Council on Tuesday, India and others submitted a text proposing that the World Trade Organization (WTO) ministerial council be "extended mutatis mutandi for the production and supply of Covid-19 therapeutics and diagnostics" https://ift.tt/p0Ak69v

No comments:

Post a Comment